COVID-19 and Acute Lupus Pneumonitis: Diagnostic and Treatment Dilemma. J Investig Med High Impact Case Rep 2020;8:2324709620933438
Date
06/06/2020Pubmed ID
32500773Pubmed Central ID
PMC7277418DOI
10.1177/2324709620933438Scopus ID
2-s2.0-85085987340 (requires institutional sign-in at Scopus site) 22 CitationsAbstract
In this article, we present a case of a young female patient with previously diagnosed lupus pneumonitis, now with a flare and new superimposed COVID-19 infection that was treated with intravenous steroids. On computed tomography scans, she had extensive interstitial lung fibrosis in addition to a positive COVID-19 polymerase chain reaction test requiring 6 L of oxygen via nasal cannula on admission. After administration of methylprednisolone, the patient improved and was weaned off her oxygen requirements and was discharged home.
Author List
Kichloo A, Aljadah M, Albosta M, Wani F, Singh J, Solanki SAuthor
Michael M. Aljadah MD Instructor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Antibodies, AntinuclearAntirheumatic Agents
Betacoronavirus
Cardiac Tamponade
Complement C3
Complement C4
Coronavirus Infections
DNA
Disease Progression
Enzyme Inhibitors
Female
Fibrin Fibrinogen Degradation Products
Glucocorticoids
Humans
Hydroxychloroquine
Lung
Lupus Erythematosus, Systemic
Lupus Nephritis
Lymphopenia
Methylprednisolone
Mycophenolic Acid
Oxygen Inhalation Therapy
Pandemics
Pneumonia
Pneumonia, Viral
Tomography, X-Ray Computed
Young Adult
